BML-277 is a highly selective inhibitor of Chk2 (IC50=15nM) displaying <25% inhibition of 35 other kinases at 10µM). It displays potent radioprotective activity and prevents apoptosis of human T cells subjected to ionizing radiation (EC50= 3-7.6µM). Useful tool for dissecting the role of Chk2 in cellular signaling.
Product Specification
| Alternative Name: | Chk2 Inhibitor II |
| |
| Formula: | C20H14ClN3O2 |
| |
| MW: | 363.8 |
| |
| Purity: | ≥98% (TLC) |
| |
| Appearance: | Off-white solid. |
| |
| CAS: | 516480-79-8 |
| |
| Solubility: | Soluble in DMSO (20mg/ml) or ethanol (20mg/ml). |
| |
| Long Term Storage: | -20°C |
| |
| Background / Technical Information: | Please click here for the comprehensive product data sheet. |
| |
Please mouse over